Science Explorer Back to mapMap
Discussion
Company · Bothell · United States

PharmaIN (United States)

pharmain.comROR OpenAlex
Research works
10
fractional, all time
Citations
52
5.4 per fractional work
Top-10% rate
5.1%
all institutions 10.0%
Open access
52%
world 40%
International
38%
world 18%
PharmaIN (United States)

Not ranked overall: PharmaIN (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PharmaIN (United States) work in?

In all years, 55% of research at PharmaIN (United States) is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (10%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 54.9% of its workMedicine: 5 fractional works · 54.9% of its workOncology: 1 fractional works · 12.9% of its workSurgery: 1 fractional works · 10.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 9.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.1% of its workHepatology: 0 fractional works · 2.4% of its workBiochemistry: 0 fractional works · 2.3% of its workEpidemiology: 0 fractional works · 2.2% of its workPathology and Forensic Medicine: 0 fractional works · 2.0% of its workPhysiology: 0 fractional works · 1.9% of its workGenetics: 0 fractional works · 1.8% of its workInfectious Diseases: 0 fractional works · 1.3% of its workComplementary and alternative medicine: 0 fractional works · 1.1% of its workGastroenterology: 0 fractional works · 1.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.1% of its workTransplantation: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workLife Sciences: 4 fractional works · 40.5% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 21.6% of its workMolecular Biology: 1 fractional works · 14.2% of its workBiotechnology: 0 fractional works · 3.4% of its workCell Biology: 0 fractional works · 1.8% of its workGenetics: 0 fractional works · 1.0% of its workMolecular Medicine: 0 fractional works · 0.8% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 10.1% of its workImmunology: 1 fractional works · 6.0% of its workMicrobiology: 0 fractional works · 3.4% of its workVirology: 0 fractional works · 0.7% of its workNeuroscience: 0 fractional works · 3.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 3.9% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 3.4% of its workPharmaceutical Science: 0 fractional works · 3.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.4% of its workPlant Science: 0 fractional works · 1.1% of its workAquatic Science: 0 fractional works · 0.3% of its workPhysical Sciences: 0 fractional works · 4.6% of its workMaterials Science: 0 fractional works · 2.9% of its workMaterials Chemistry: 0 fractional works · 2.4% of its workBiomaterials: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 1.8% of its workOrganic Chemistry: 0 fractional works · 1.8% of its workALL ITS WORKPharmaIN (UnitedStates)10fractional works, all years
Life Sciences40%Physical Sciences5%Health Sciences55%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Medicine554.9%
    1. Biochemistry, Genetics and Molecular Biology221.6%
    2. Immunology and Microbiology110.1%
    3. Neuroscience03.9%
    4. Pharmacology, Toxicology and Pharmaceutics03.4%
    5. Agricultural and Biological Sciences01.4%
    1. Materials Science02.9%
    2. Chemistry01.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at PharmaIN (United States)?

Ranked on the quality score, Elijah M. Bolotin and Colin B. Bier lead among researchers whose main affiliation is PharmaIN (United States).

  1. 1 Elijah M. Bolotin United States · #2,182,222 worldwide 738 citations · 21 works
  2. 2 Colin B. Bier United States · #3,796,506 worldwide 58 citations · 16 works
All ranked researchers at PharmaIN (United States)

What are the most cited papers from PharmaIN (United States)?

The most cited paper from PharmaIN (United States) is "Melanoidin, a Food Protein‐Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo" (Shigeru Hiramoto, Kazuro Itoh, Satomi Shizuuchi et al., 2004), with 63 citations. Next come "Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes" (53) and "Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs" (29).

Most cited papers
#PaperReleasedCitations
1 Melanoidin, a Food Protein‐Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo Shigeru Hiramoto, Kazuro Itoh, Satomi Shizuuchi et al. · Helicobacter 9 Sep 2004 63
2 Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes Zdravka O. Medarova, G. Castillo, Guangping Dai et al. · Diabetes Open access 5 Sep 2007 53
3 Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs Alexei A. Bogdanov Jr, Mary L. Mazzanti, Gerardo M. Castillo et al. · Theranostics Open access 2012 29
4 Effects of catechin-rich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells Kensuke Yasui, Hiroki Tanabe, Norihisa Okada et al. · Biomedical Research Open access 2010 20
5 The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution Beverly A. Teicher, Hans-Peter Biemann, George Vande Woude et al. · International Journal of Oncology Open access Apr 2008 18
All 19 most cited papers, with filters and sorting

Which research topics does PharmaIN (United States) publish most on?

By volume in 2022-now: Muscle metabolism and nutrition, Muscle Physiology and Disorders, Polyamine Metabolism and Applications and Advanced Nanomaterials in Catalysis.

Muscle metabolism and nu…0Muscle metabolism and nutrition: 0 fractional worksMuscle Physiology and Di…0Muscle Physiology and Disorders: 0 fractional worksPolyamine Metabolism and…0Polyamine Metabolism and Applications: 0 fractional worksAdvanced Nanomaterials i…0Advanced Nanomaterials in Catalysis: 0 fractional worksElectrolyte and hormonal disorders: 0 fractional worksOrgan Transplantation Techniques and Outcomes: 0 fractional worksLiver Disease and Transp…0Liver Disease and Transplantation: 0 fractional worksAtherosclerosis and Cardiovascular Diseases: 0 fractional worksTea Polyphenols and Effects: 0 fractional worksCarbon and Quantum Dots …0Carbon and Quantum Dots Applications: 0 fractional works
Cell BiologyMolecular BiologyMaterials ChemistryPulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Muscle metabolism and nutrition Cell Biology 0 works
  2. 2 Muscle Physiology and Disorders Molecular Biology 0 works
  3. 3 Polyamine Metabolism and Applications Molecular Biology 0 works
  4. 4 Advanced Nanomaterials in Catalysis Materials Chemistry 0 works
  5. 5 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works
  6. 6 Organ Transplantation Techniques and Outcomes Surgery 0 works
  7. 7 Liver Disease and Transplantation Hepatology 0 works
  8. 8 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  9. 9 Tea Polyphenols and Effects Pathology and Forensic Medicine 0 works
  10. 10 Carbon and Quantum Dots Applications Materials Chemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.7%not open48.3%

World: 40% of research is openly available.

with international co-authors38.0%domestic only62.0%

World: 18% is written across borders.

How has PharmaIN (United States)'s research output changed?

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PharmaIN (United States) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.000020%0.000040%0.000060%PharmaIN (United States)0.0000043% in 202520102020

Fractional works of PharmaIN (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bothell

All research institutions in Bothell

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PharmaIN (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.